SULFATE AND CYSTEINE LEVELS IN THE PLASMA OF PATIENTS WITH PARKINSONS-DISEASE

Authors
ALLAIN P LEBOUIL A CORDILLET E LEQUAY L BAGHERI H MONTASTRUC JL
Citation
P. Allain et al., SULFATE AND CYSTEINE LEVELS IN THE PLASMA OF PATIENTS WITH PARKINSONS-DISEASE, Neurotoxicology, 16(3), 1995, pp. 527-529
Citations number
9
Categorie Soggetti
Pharmacology & Pharmacy",Neurosciences
Journal title
Neurotoxicology → ACNP
ISSN journal
0161813X
Volume
16
Issue
3
Year of publication
1995
Pages
527 - 529
Database
ISI
SICI code
0161-813X(1995)16:3<527:SACLIT>2.0.ZU;2-#
Abstract
The study of Heafield et al. (1990) has prompted us to compare the lev els of sulfate cysteine and homocysteine in the plasma of healthy subj ects and of patients with Parkinson's disease treated by L-Dopa and do pa decarboxylase inhibitors. The levels of sulfate and cysteine in the plasma of controls and patients with Parkinson's disease were not sta tistically different but the level of homocysteine was higher in patie nts. (C) 1995 Intox Press, Inc.